| Findings, by clinical measure | Study design | Nonrandomized controlled trials | Randomized controlled trials | Yoga versus baseline | Yoga versus controls | Yoga versus baseline | Yoga versus controls |
| Measures of insulin resistance | | | | | Fasting glucose | 14.33–33.23% [38, 40–44, 46–48] | 9.87–29.75% [39, 41, 42, 45, 49] | 7.21–27.53% [57, 60, 63, 64, 66] | 13.46–36.2% [51, 61, 63, 66, 70] | Postprandial glucose | 5.92–38.65% [40, 42–44, 46, 48] | 11.61–35.5% [42, 45] | 7.03–18.89% [57, 63, 64] | 11.17–14.22% [55, 63] | Fasting glycosylated hemoglobin (HbA1c) | 1.55–21.23% [41–44] | 1.03–7.44% [39, 41, 42, 45, 49] | 0.31–14.17% [57, 63, 67] | 7.77–17.78% [61, 67, 70] | Blood lipid profiles | | | | | Total cholesterol | 5.97–14.61% [38, 40, 42, 47, 48] | 4.11–8.63% [39, 42, 49] | 1.37–37.01% [57, 58, 63, 66, 69] | 4.74–18.3% [61, 63, 66, 69] | Triglycerides | 3.97–16.35% [40, 42, 44, 47, 48] | 3.53% [42] | 14.33–38.0% [57, 58, 69] | 1.06–10.96% [51, 61, 69] | Low-density lipoprotein (LDL) | 2.18–14.88% [42, 44, 48] | 1.38–15.05% [39, 42, 49] | 8.33–48.45% [57, 58, 63, 69] | 3.39–11.42% [57, 61, 63, 69] | High-density lipoprotein (HDL) | 8.28–15.21% [42, 48] | 5.01–24.96% [39, 42, 49] | 6.99–101.59% [57, 69] | 9.1–54.92% [57, 61, 69] | Very low-density lipoprotein (VLDL) | 15.17–16.06% [42, 48] | 13.28% [49] | 7.23–22.66% [57, 66] | | Anthropometric measures | | | | | BMI | 7.52–10.34% [44] | 2.72–3.56% [45, 49] | | 4.32% [67] | Body weight | 3.48–6.95% [38, 44, 48] | | | 4.18% [58] | Waist-hip circumference ratio | 5.38–8.99% [44, 47] | 3.17% [49] | | 5.32% [58] | Blood pressure | | | | | Systolic blood pressure | 11.27% [47] | 5.03% [49] | | | Diastolic blood pressure | 12.92% [47] | 3.46% [49] | | |
|
|